Key Takeaways
- Over the past year, RKLB stock has surged 43.7%, significantly outperforming competitors in the aerospace sector.
- ARK Investment Management, led by Cathie Wood, acquired more than 705,000 shares of RKLB in two trading sessions, totaling approximately $44 million.
- CEO Peter Beck indicated that the launch window for Neutron before year’s end is “narrowing,” positioning it as both the company’s primary opportunity and main vulnerability.
- Blue Origin secured a $700 million NASA contract for Mars telecommunications, dealing a setback to investor confidence in RKLB.
- The company’s contract backlog reached an all-time high of $2.36 billion, representing a 137% year-over-year increase and ensuring revenue visibility.
Shares of Rocket Lab (RKLB) are currently trading near $62.54, down 2.2% in Tuesday’s session and more than 50% below the peak reached in May. However, this hasn’t deterred ARK Investment Management from accumulating shares aggressively, purchasing 705,102 shares across two sessions valued at approximately $44 million.
On Tuesday specifically, ARK purchased 504,799 shares distributed among three of its ETFs, representing roughly $31.6 million based on Tuesday’s closing price.
This accumulation activity occurs as RKLB has declined in nine out of the past ten trading sessions, with additional losses registered in after-hours trading.
Analyst sentiment remains largely constructive despite price target adjustments. Bank of America analyst Ronald Epstein reduced his price objective to $110 from $115 on August 31, partially accounting for anticipated share dilution, while maintaining his Buy recommendation. This adjusted target still represents approximately 76% potential upside from Tuesday’s closing level.
Following second-quarter earnings, Cantor Fitzgerald’s Andres Sheppard increased his price target to $122 from $96, identifying Neutron as “the most material catalyst.” Meanwhile, Roth Capital’s Suji Desilva lowered his target to $110 from $130 but retained his Buy rating, emphasizing that the record backlog provides “meaningful near-term revenue coverage.”
Neutron’s Critical Timeline
The Rocket Lab Neutron rocket represents the primary focus for investors. The company envisions Neutron as its gateway into the medium-lift launch segment, substantially broadening its market opportunity beyond Electron’s small-satellite niche.
However, following Q2 earnings, CEO Peter Beck acknowledged that the opportunity for a maiden launch before year-end is “narrowing.” Critical testing phases must still be successfully completed before the rocket can fly. Any additional delays to Neutron’s debut would postpone the growth trajectory that supports many analysts’ bullish price projections.
The orbital launch industry continues to face supply constraints, positioning Rocket Lab favorably if operational execution remains strong. Electron has successfully completed 87 missions to date, while HASTE provides support for government initiatives. The company has secured over 90 launches spanning Electron, HASTE, and Neutron platforms.
Blue Origin Contract Win and Backlog Strength
Market sentiment weakened further when NASA announced after Tuesday’s close that Blue Origin had won the Mars Telecommunications Network contract. This firm-fixed-price agreement carries a potential value of up to $700 million, with Blue Origin responsible for delivering a Mars orbiter by late 2028. Rocket Lab had been among the eligible bidders for this contract.
Despite this setback, the company’s Q2 2026 backlog reached a record $2.36 billion, climbing 137% compared to the prior year period. Approximately 45.5% of this backlog is projected to convert to revenue within the next 12 months.
Recent acquisitions of Mynaric and Motiv have expanded the company’s technological capabilities in optical communications and robotics. In August 2026, Rocket Lab was selected for the U.S. Space Force’s NITE-STAR IDIQ program, a contract with a $981 million ceiling value encompassing both space and ground infrastructure.
Consensus EPS estimates for RKLB in 2026 have increased 44.44% during the past 60 days. The company maintains a total debt to capital ratio of just 0.83%, significantly below the industry benchmark of 61.47%. Its current ratio stands at 5.48, compared to the industry average of 2.06.
RKLB currently trades at 31.3X forward Price/Sales, representing a substantial premium compared to the industry’s 7.64X multiple.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
